Skip to main content
. 2009 Oct 20;50(5):601–612. doi: 10.3349/ymj.2009.50.5.601

Fig. 4.

Fig. 4

Survival outcome after treatment with either TACE alone (broken line) or TACE plus radiotherapy (solid line) for similar clinical group of HCC patients. The 2 year survival rate appears higher in TACE plus radiotherapy group (36% vs. 14%, p < 0.05, Log-rank test). TACE, transarterial chemoembolization; TACE + RT, transarterial chemoembolization radiotherapy; HCC, Hepatocellular carcinoma.